Boston Scientific Corp (BSX)

95.95 +3.96 (+4.30%) USD  |  NYSE  |  Jan 08, 16:00
96.29 +0.34 (+0.35%) After-Hours: 20:00
More

Boston Scientific SG&A Expense (Quarterly): 1.562B for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for BSX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Haemonetics Corp 106.95M
ResMed Inc 238.98M
Globus Medical Inc 240.74M
Baxter International Inc 754.00M
Abbott Laboratories 2.895B